Research Highlights

 

 
In Memorium: Dr. Philip Gordon
The Board of Directors and members of staff of the Jewish General Hospital are greatly saddened by the passing of Dr. Philip Gordon, founding Chief of the JGH Division of Colorectal Surgery, founding Presi...

  [MORE...]


 
Smoking in patients with heart attack reduced with varenicline
Patients who smoke after an acute coronary syndrome, including a heart attack (myocardial infarction) or unstable angina (reduced blood flow to the heart) are at increased risk of another attack and death ...

  [MORE...]


 
Use of certain diabetes drugs may be linked to increased risk of inflammatory bowel disease
Use of certain diabetes drugs, known as dipeptidyl peptidase-4 inhibitors, is associated with an increased risk of inflammatory bowel disease, the digestive condition that causes stomach pain and bloating,...

  [MORE...]


 
Clinical trial reveals that aspirin is effective at preventing venous thromboembolism following major orthopedic surgeries
Patients at the Jewish General Hospital were among the participants in a large clinical trial that discovered that aspirin was as effective as a gold standard anti-coagulant at preventing dangerous blood c...

  [MORE...]


 
New funding to strengthen proteomics research
New funding from Genome Canada and Genome BC will enhance efforts to translate research into new approaches for diagnosis and treatment of cancer.

  [MORE...]


 
Canadian Brain Bank Network to advance Alzheimer research
The Government of Canada announced a grant of $1,065,000 over five years to establish a Canadian brain bank network that will be linked to the international Alzheimer’s Disease Neuroimaging Initiativ...

  [MORE...]


 
Flawed research methods exaggerate the prevalence of depression
A new study concludes that researchers commonly over-estimate the prevalence of depression by using self-report screening tools not meant to diagnose depression.

  [MORE...]


 
Andréa LeBlanc awarded Senate 150th Anniversary Medal
Dr. LeBlanc is internationally recognized for her pioneering research into Alzheimer disease.

  [MORE...]


 
Clinical trial of novel approach to treating osteoporosis represents “significant breakthrough,” according to clinician-scientist at the Lady Davis Institute
The results of a large-scale multi-centre international phase 3 clinical trial shows that an innovative drug combination can significantly lower the risk of fracture among high risk patients with osteoporo...

  [MORE...]

1234567
Support research at the Lady Davis Institute - Jewish General Hospital